You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Hepatitis C Virus Core 24 protein (ab67735)

Overview

  • Product nameHepatitis C Virus Core 24 protein
  • Protein descriptionRecombinant full length protein containing the Hepatitis C Virus core nucleocapsid immunodominant regions.
  • Expression hostE. coli
  • Properties

  • Purity> 95 % by SDS-PAGE
  • Purification notesHepatitis C Virus Core 24 protein was purified by a proprietary chromatographic technique.
  • Biological activityThis protein is immunoreactive with sera of Hepatitis C Virus-infected individuals. The HCV Core 24 genotype-1b, E.coli derived recombinant protein, contains the HCV core nucleocapsid immunodominant regions. The protein is fused with b-galactosidase (114 kDa) at N-terminus.
  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferPreservative: None
    Constituents: 50% Glycerol, 1.5M Urea, 25mM Tris HCl, 1mM EDTA, pH 8.0
  • Concentration information loading...
  • Research Areas
  • Applications

    Our Abpromise guarantee covers the use of ab67735 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Notes
    WB WB: Use at an assay dependent dilution.
    ELISA ELISA: Use at an assay dependent dilution.

    Protein info

    • Alternative names
        HCV core 24Hepatitis C virus core protein
  • RelevanceHepatitis C Virus (HCV) is a small 50nm, enveloped, single-stranded, positive sense RNA virus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes (1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
  • References for Hepatitis C Virus Core 24 protein (ab67735)

    ab67735 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab67735.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"